Related references
Note: Only part of the references are listed.Female Androgenetic Alopecia: An Update on Diagnosis and Management
Michela Starace et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2020)
Treatment of acne with spironolactone: a retrospective review of 395 adult patients at Mayo Clinic, 2007-2017
E. E. Roberts et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)
Current Issues in the Treatment of Acne Vulgaris
Kaiane A. Habeshian et al.
PEDIATRICS (2020)
Pharmacological Approaches to Controlling Cardiometabolic Risk in Women with PCOS
Andrea Cignarella et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Licorice: From Pseudohyperaldosteronism to Therapeutic Uses
Chiara Sabbadin et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Aldosterone in Gynecology and Its Involvement on the Risk of Hypertension in Pregnancy
Chiara Sabbadin et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society* Clinical Practice Guideline
Kathryn A. Martin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Long-Term Response of Hirsutism and Other Hyperandrogenic Symptoms to Combination Therapy in Polycystic Ovary Syndrome
Uche Ezeh et al.
JOURNAL OF WOMENS HEALTH (2018)
Spironolactone in the treatment of polycystic ovary syndrome
Decio Armanini et al.
EXPERT OPINION ON PHARMACOTHERAPY (2016)
Spironolactone and intermenstrual bleeding in polycystic ovary syndrome with normal BMI
C. Sabbadin et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2016)
Low Usefulness of Potassium Monitoring Among Healthy Young Women Taking Spironolactone for Acne
Molly Plovanich et al.
JAMA DERMATOLOGY (2015)
Spironolactone use and the risk of breast and gynecologic cancers
Robert J. Biggar et al.
CANCER EPIDEMIOLOGY (2013)
Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society
H. F. Escobar-Morreale et al.
HUMAN REPRODUCTION UPDATE (2012)
Polycystic ovary syndrome: Implications of measurement of plasma aldosterone, renin activity and progesterone
Decio Armanini et al.
STEROIDS (2012)
Spironolactone and risk of incident breast cancer in women older than 55 years: retrospective, matched cohort study
Isla S. Mackenzie et al.
BMJ-BRITISH MEDICAL JOURNAL (2012)
Development and validation of a comprehensive acne severity scale
Jerry K. L. Tan et al.
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY (2007)
Treatment of polycystic ovary syndrome with spironolactone plus licorice
Decio Armanini et al.
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2007)
Treatment of female pattern hair loss with oral antiandrogens
R Sinclair et al.
BRITISH JOURNAL OF DERMATOLOGY (2005)
Spironolactone in the treatment of polycystic ovary syndrome: Effects on clinical features, insulin sensitivity and lipid profile
E Zuhan et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2005)
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
BCJM Fauser et al.
HUMAN REPRODUCTION (2004)
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
J Chang et al.
FERTILITY AND STERILITY (2004)
Use of cyproterone acetate, finasteride, and spironolactone to treat idiopathic hirsutism
F Lumachi et al.
FERTILITY AND STERILITY (2003)
Comparison of spironolactone, flutamide, and finasteride efficacy in the treatment of hirsutism: A randomized, double blind, placebo-controlled trial
P Moghetti et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2000)
Share Paper
